Showing results (11-20 of 6,632) with videos related to

Sort By:
Pageof 664
Clinical Pharmacology and Therapeutics|August 1, 1992
Epoetin enhances erythropoiesis in normal men undergoing repeated phlebotomiesP A Abraham, C E Halstenson, M M Macres, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatinA L Mazzu, K C Lasseter, E C Shamblen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1992
Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacinR W Frost, K C Lasseter, A J Noe, et al.
Journal of Clinical Pharmacology|May 20, 1998
Pharmacokinetics and pharmacodynamics of irbesartan in patients with hepatic cirrhosisM R Marino, K M Langenbacher, R H Raymond, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1991
The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral doseF Waldmeier, G Kaiser, R Ackermann, et al.
Journal of Clinical Pharmacology|April 29, 1998
Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humansM T Marino, B G Schuster, R P Brueckner, et al.
Pharmacotherapy|May 1, 1986
Once- and twice-daily nitrendipine in patients with hypertension and noninsulin-dependent diabetesT C Fagan, E B Nelson, K C Lasseter, et al.
Journal of Clinical Pharmacology|February 1, 1995
Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairmentN F Ford, K C Lasseter, D R Van Harken, et al.
European Journal of Clinical Pharmacology|March 1, 2003
Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairmentS G Simonson, P D Martin, P Mitchell, et al.
Pageof 664